BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brunn D, Turkowski K, Günther S, Weigert A, Muley T, Kriegsmann M, Winter H, Dammann RH, Stathopoulos GT, Thomas M, Guenther A, Grimminger F, Pullamsetti SS, Seeger W, Savai R. Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican. Cancers (Basel) 2021;13:E208. [PMID: 33430083 DOI: 10.3390/cancers13020208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Wu Y, Yu S, Qiao H. Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer. Front Pharmacol 2022;13:990445. [DOI: 10.3389/fphar.2022.990445] [Reference Citation Analysis]
2 Karagiannis D, Rampias T. Cancer Evolution in Precision Medicine Era. Cancers 2022;14:1885. [DOI: 10.3390/cancers14081885] [Reference Citation Analysis]
3 Sharma BR, Karki R, Sundaram B, Wang Y, Vogel P, Kanneganti T. The Transcription Factor IRF9 Promotes Colorectal Cancer via Modulating the IL-6/STAT3 Signaling Axis. Cancers 2022;14:919. [DOI: 10.3390/cancers14040919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sauerer T, Lischer C, Weich A, Berking C, Vera J, Dörrie J. Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines. Front Microbiol 2021;12:785662. [PMID: 35003017 DOI: 10.3389/fmicb.2021.785662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu J, Leng X, Pan Z, Xu L, Zhang H. Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma. Int J Gen Med 2021;14:5675-92. [PMID: 34557022 DOI: 10.2147/IJGM.S328225] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]